Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study
Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.
Source: medscape.com
Page 4 - Oard Recertification News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oard Recertification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oard Recertification Today - Breaking & Trending Today
Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa
Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.
Source: medscape.com
Optometrist Sues After Firing On Return From Maternity Leave
Lawsuit claimed Seattle-area eye surgery practice engaged in gender discrimination and workplace retaliation.
Source: medscape.com
Ad Campaign for Weight-Loss Drugs Reinforces Proper Use
Eli Lilly and Company, which manufactures one of the new weight-loss drugs, has launched an advertising campaign reinforcing that the drugs should not be used for cosmetic weight loss.
Source: medscape.com
Sarcopenic Obesity Predicts Earlier Death
A recent study evaluated the association between sarcopenia and sarcopenic obesity with mortality risk.
Source: medscape.com